Go Pro

Agilon Health (AGL) Competitors

Agilon Health logo
$96.32 +3.59 (+3.87%)
As of 08/21/2026 03:58 PM Eastern

AGL vs. RDNT, LFST, BLLN, OPCH, and CRVL

Should you buy Agilon Health stock or one of its competitors? Agilon Health's main competitors and comparable companies include RadNet (RDNT), LifeStance Health Group (LFST), Billiontoone (BLLN), Option Care Health (OPCH), and CorVel (CRVL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Agilon Health compare to RadNet?

Agilon Health (NYSE:AGL) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, RadNet had 1 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for RadNet and 4 mentions for Agilon Health. RadNet's average media sentiment score of 1.72 beat Agilon Health's score of 0.50 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Agilon Health presently has a consensus price target of $91.30, suggesting a potential downside of 5.21%. RadNet has a consensus price target of $88.00, suggesting a potential upside of 14.55%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
RadNet
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.89

Agilon Health has a beta of 3.01, meaning that its share price is 201% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market.

RadNet has a net margin of -0.93% compared to Agilon Health's net margin of -3.92%. RadNet's return on equity of 2.61% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
RadNet -0.93%2.61%0.91%

77.9% of RadNet shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

RadNet has lower revenue, but higher earnings than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.27-$391.35M-$14.27N/A
RadNet$2.04B2.96-$18.65M-$0.27N/A

Summary

RadNet beats Agilon Health on 13 of the 16 factors compared between the two stocks.

How does Agilon Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

LifeStance Health Group has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.01, suggesting that its stock price is 201% more volatile than the broader market.

LifeStance Health Group has a net margin of 3.19% compared to Agilon Health's net margin of -3.92%. LifeStance Health Group's return on equity of 3.39% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group3.19% 3.39% 2.33%
Agilon Health -3.92%-119.38%-16.85%

LifeStance Health Group currently has a consensus target price of $12.38, indicating a potential downside of 0.76%. Agilon Health has a consensus target price of $91.30, indicating a potential downside of 5.21%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, equities analysts clearly believe LifeStance Health Group is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Comparatively, 2.5% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, LifeStance Health Group had 3 more articles in the media than Agilon Health. MarketBeat recorded 7 mentions for LifeStance Health Group and 4 mentions for Agilon Health. LifeStance Health Group's average media sentiment score of 0.70 beat Agilon Health's score of 0.50 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeStance Health Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.40$9.66M$0.1395.92
Agilon Health$5.93B0.27-$391.35M-$14.27N/A

Summary

LifeStance Health Group beats Agilon Health on 15 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Billiontoone currently has a consensus target price of $126.71, suggesting a potential upside of 33.34%. Agilon Health has a consensus target price of $91.30, suggesting a potential downside of 5.21%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts clearly believe Billiontoone is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21

Billiontoone has a net margin of 8.04% compared to Agilon Health's net margin of -3.92%. Billiontoone's return on equity of 9.96% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone8.04% 9.96% 5.35%
Agilon Health -3.92%-119.38%-16.85%

Billiontoone has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$397.41M11.28$7.45M$0.70135.76
Agilon Health$5.93B0.27-$391.35M-$14.27N/A

In the previous week, Agilon Health had 2 more articles in the media than Billiontoone. MarketBeat recorded 4 mentions for Agilon Health and 2 mentions for Billiontoone. Agilon Health's average media sentiment score of 0.50 beat Billiontoone's score of 0.00 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Billiontoone beats Agilon Health on 10 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Option Care Health?

Agilon Health (NYSE:AGL) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Agilon Health has a beta of 3.01, indicating that its share price is 201% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

Option Care Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.27-$391.35M-$14.27N/A
Option Care Health$5.65B0.63$207.59M$1.3317.82

98.1% of Option Care Health shares are held by institutional investors. 2.5% of Agilon Health shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Option Care Health has a net margin of 3.68% compared to Agilon Health's net margin of -3.92%. Option Care Health's return on equity of 18.74% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
Option Care Health 3.68%18.74%7.25%

Agilon Health presently has a consensus target price of $91.30, indicating a potential downside of 5.21%. Option Care Health has a consensus target price of $29.92, indicating a potential upside of 26.26%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts clearly believe Option Care Health is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Option Care Health
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Agilon Health had 4 more articles in the media than Option Care Health. MarketBeat recorded 4 mentions for Agilon Health and 0 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.26 beat Agilon Health's score of 0.50 indicating that Option Care Health is being referred to more favorably in the news media.

Company Overall Sentiment
Agilon Health Positive
Option Care Health Positive

Summary

Option Care Health beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does Agilon Health compare to CorVel?

CorVel (NASDAQ:CRVL) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

CorVel has a net margin of 11.72% compared to Agilon Health's net margin of -3.92%. CorVel's return on equity of 29.92% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CorVel11.72% 29.92% 17.82%
Agilon Health -3.92%-119.38%-16.85%

CorVel has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, Agilon Health has a beta of 3.01, indicating that its share price is 201% more volatile than the broader market.

51.4% of CorVel shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CorVel has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CorVel$958.53M3.73$110.34M$2.2531.18
Agilon Health$5.93B0.27-$391.35M-$14.27N/A

In the previous week, Agilon Health had 1 more articles in the media than CorVel. MarketBeat recorded 4 mentions for Agilon Health and 3 mentions for CorVel. CorVel's average media sentiment score of 1.77 beat Agilon Health's score of 0.50 indicating that CorVel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CorVel
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Agilon Health
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilon Health has a consensus target price of $91.30, indicating a potential downside of 5.21%. Given Agilon Health's stronger consensus rating and higher probable upside, analysts plainly believe Agilon Health is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21

Summary

CorVel beats Agilon Health on 10 of the 16 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricAgilon HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.62B$9.83B$7.37B$24.30B
Dividend YieldN/A2.55%2.53%3.70%
P/E Ratio-6.7534.38272.8830.31
Price / Sales0.274.97618.9619.89
Price / CashN/A125.1278.6232.49
Price / Book7.114.0513.056.77
Net Income-$391.35M$311.06M$3.47B$1.07B
7 Day Performance-0.31%0.83%2.09%-0.65%
1 Month Performance-3.32%2.42%6.64%3.38%
1 Year Performance190.78%15.69%25.02%14.90%

Agilon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
Agilon Health
1.0879 of 5 stars
$96.32
+3.9%
$91.30
-5.2%
+190.8%$1.62B$5.93BN/A1,076
RDNT
RadNet
3.1239 of 5 stars
$75.93
-0.6%
$88.00
+15.9%
+9.6%$6.01B$2.04BN/A11,264
LFST
LifeStance Health Group
3.0646 of 5 stars
$12.55
+1.0%
$12.13
-3.4%
+124.7%$4.82B$1.42B96.5510,961
BLLN
Billiontoone
4.139 of 5 stars
$93.91
+0.6%
$126.71
+34.9%
N/A$4.40B$305.11M134.16620
OPCH
Option Care Health
4.1355 of 5 stars
$23.37
-2.4%
$29.92
+28.0%
-17.5%$3.59B$5.65B17.578,266

Related Companies and Tools


This page (NYSE:AGL) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners